Safety and treatment patterns of multikinase inhibitors in patients with ... - 7thSpace Interactive (press release) PDF Print
7thSpace Interactive (press release)
Multikinase inhibitors (MKIs) sunitinib and sorafenib have become a standard ofcare for metastatic renal cell carcinoma (mRCC). This study assessed safety and treatmentpatterns for these agents in a real-world clinical practice setting in Italy.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.